July 2013 FDA Recall Drug by Vistapharm, Inc.
D-913-2013 - Failed Impurites/Degradation Specifications

This Class II drug recall was voluntarily initiated by Vistapharm, Inc. on July 4, 2013 for the product Drug. The FDA reported the reason for recall as failed impurites/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-913-2013

Reason for Recall
Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
Initiated
07-04-2013
Reported
08-28-2013
Quantity
1,707,050 cups / 5ml ea.

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771

Batch or Lot Expiration Information

Lot# 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13.